Annual CFO
$8.01 B
-$1.07 B-11.75%
31 December 2023
Summary:
Gilead Sciences annual cash flow from operations is currently $8.01 billion, with the most recent change of -$1.07 billion (-11.75%) on 31 December 2023. During the last 3 years, it has fallen by -$3.38 billion (-29.67%). GILD annual CFO is now -62.32% below its all-time high of $21.25 billion, reached on 31 December 2015.GILD Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$4.31 B
+$2.98 B+225.21%
30 September 2024
Summary:
Gilead Sciences quarterly cash flow from operations is currently $4.31 billion, with the most recent change of +$2.98 billion (+225.21%) on 30 September 2024. Over the past year, it has increased by +$2.14 billion (+98.66%). GILD quarterly CFO is now -25.64% below its all-time high of $5.79 billion, reached on 31 December 2015.GILD Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$10.02 B
+$2.55 B+34.20%
30 September 2024
Summary:
Gilead Sciences TTM cash flow from operations is currently $10.02 billion, with the most recent change of +$2.55 billion (+34.20%) on 30 September 2024. Over the past year, it has increased by +$2.02 billion (+25.18%). GILD TTM CFO is now -52.84% below its all-time high of $21.25 billion, reached on 31 December 2015.GILD TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +98.7% | +25.2% |
| 3 y3 years | -29.7% | +34.5% | -12.0% |
| 5 y5 years | -12.4% | +67.0% | +9.6% |
GILD Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -29.7% | at low | at high | +225.2% | -12.0% | +34.2% |
| 5 y | 5 years | -29.7% | at low | at high | +225.2% | -12.0% | +34.2% |
| alltime | all time | -62.3% | +6405.0% | -25.6% | +3147.4% | -52.8% | +7992.6% |
Gilead Sciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.31 B(+225.2%) | $10.02 B(+34.2%) |
| June 2024 | - | $1.32 B(-40.3%) | $7.47 B(-11.9%) |
| Mar 2024 | - | $2.22 B(+2.3%) | $8.48 B(+5.9%) |
| Dec 2023 | $8.01 B(-11.8%) | $2.17 B(+23.6%) | $8.01 B(-4.7%) |
| Sept 2023 | - | $1.75 B(-24.9%) | $8.40 B(-11.6%) |
| June 2023 | - | $2.34 B(+34.1%) | $9.51 B(+6.0%) |
| Mar 2023 | - | $1.74 B(-32.1%) | $8.98 B(-1.1%) |
| Dec 2022 | $9.07 B(-20.3%) | $2.57 B(-10.3%) | $9.07 B(-6.6%) |
| Sept 2022 | - | $2.86 B(+58.9%) | $9.71 B(-3.9%) |
| June 2022 | - | $1.80 B(-2.1%) | $10.10 B(-4.8%) |
| Mar 2022 | - | $1.84 B(-42.6%) | $10.61 B(-6.8%) |
| Dec 2021 | $11.38 B(+39.4%) | $3.21 B(-1.5%) | $11.38 B(+12.8%) |
| Sept 2021 | - | $3.25 B(+40.5%) | $10.10 B(+11.0%) |
| June 2021 | - | $2.32 B(-11.3%) | $9.09 B(-2.7%) |
| Mar 2021 | - | $2.61 B(+36.2%) | $9.34 B(+14.4%) |
| Dec 2020 | $8.17 B(-10.7%) | $1.92 B(-14.8%) | $8.17 B(-7.5%) |
| Sept 2020 | - | $2.25 B(-12.3%) | $8.83 B(-4.3%) |
| June 2020 | - | $2.57 B(+78.7%) | $9.23 B(+2.5%) |
| Mar 2020 | - | $1.44 B(-44.3%) | $9.00 B(-1.5%) |
| Dec 2019 | $9.14 B(+8.9%) | $2.58 B(-2.5%) | $9.14 B(+2.6%) |
| Sept 2019 | - | $2.65 B(+12.9%) | $8.91 B(+5.1%) |
| June 2019 | - | $2.34 B(+48.5%) | $8.48 B(+10.0%) |
| Mar 2019 | - | $1.58 B(-32.8%) | $7.71 B(-8.3%) |
| Dec 2018 | $8.40 B(-29.4%) | $2.35 B(+6.0%) | $8.40 B(-4.6%) |
| Sept 2018 | - | $2.21 B(+40.6%) | $8.81 B(-5.2%) |
| June 2018 | - | $1.57 B(-30.7%) | $9.29 B(-17.4%) |
| Mar 2018 | - | $2.27 B(-17.5%) | $11.24 B(-5.5%) |
| Dec 2017 | $11.90 B(-30.2%) | $2.75 B(+2.2%) | $11.90 B(-6.2%) |
| Sept 2017 | - | $2.69 B(-23.6%) | $12.68 B(-11.8%) |
| June 2017 | - | $3.53 B(+20.5%) | $14.38 B(-9.2%) |
| Mar 2017 | - | $2.92 B(-17.3%) | $15.84 B(-7.1%) |
| Dec 2016 | $17.05 B(-19.8%) | $3.54 B(-19.4%) | $17.05 B(-11.7%) |
| Sept 2016 | - | $4.39 B(-11.9%) | $19.30 B(+1.6%) |
| June 2016 | - | $4.99 B(+20.7%) | $19.01 B(-3.4%) |
| Mar 2016 | - | $4.13 B(-28.7%) | $19.68 B(-7.4%) |
| Dec 2015 | $21.25 B(+65.8%) | $5.79 B(+41.5%) | $21.25 B(+15.0%) |
| Sept 2015 | - | $4.10 B(-27.6%) | $18.48 B(+0.3%) |
| June 2015 | - | $5.66 B(-0.8%) | $18.42 B(+8.7%) |
| Mar 2015 | - | $5.70 B(+88.7%) | $16.95 B(+32.2%) |
| Dec 2014 | $12.82 B(+312.8%) | $3.02 B(-25.3%) | $12.82 B(+21.8%) |
| Sept 2014 | - | $4.04 B(-3.4%) | $10.52 B(+45.5%) |
| June 2014 | - | $4.18 B(+166.9%) | $7.23 B(+80.8%) |
| Mar 2014 | - | $1.57 B(+115.7%) | $4.00 B(+28.9%) |
| Dec 2013 | $3.10 B(-2.8%) | $726.80 M(-3.5%) | $3.10 B(+0.7%) |
| Sept 2013 | - | $753.10 M(-21.0%) | $3.08 B(+0.3%) |
| June 2013 | - | $953.00 M(+41.8%) | $3.08 B(-9.9%) |
| Mar 2013 | - | $672.10 M(-4.8%) | $3.41 B(+6.9%) |
| Dec 2012 | $3.19 B(-12.2%) | $706.01 M(-5.3%) | $3.19 B(-7.8%) |
| Sept 2012 | - | $745.37 M(-42.2%) | $3.47 B(-4.2%) |
| June 2012 | - | $1.29 B(+184.9%) | $3.62 B(+10.6%) |
| Mar 2012 | - | $452.97 M(-53.7%) | $3.27 B(-10.1%) |
| Dec 2011 | $3.64 B(+28.4%) | $978.11 M(+9.0%) | $3.64 B(+7.5%) |
| Sept 2011 | - | $897.11 M(-4.9%) | $3.39 B(+4.9%) |
| June 2011 | - | $943.25 M(+15.0%) | $3.23 B(+8.2%) |
| Mar 2011 | - | $820.54 M(+13.2%) | $2.98 B(+5.3%) |
| Dec 2010 | $2.83 B(-8.0%) | $724.84 M(-2.0%) | $2.83 B(-7.5%) |
| Sept 2010 | - | $739.42 M(+5.8%) | $3.06 B(-3.8%) |
| June 2010 | - | $699.08 M(+4.3%) | $3.19 B(+2.4%) |
| Mar 2010 | - | $670.57 M(-29.8%) | $3.11 B(+0.9%) |
| Dec 2009 | $3.08 B(+43.7%) | $955.28 M(+11.0%) | $3.08 B(+13.7%) |
| Sept 2009 | - | $860.53 M(+38.1%) | $2.71 B(+14.8%) |
| June 2009 | - | $622.92 M(-2.9%) | $2.36 B(+8.3%) |
| Mar 2009 | - | $641.33 M(+9.7%) | $2.18 B(+1.7%) |
| Dec 2008 | $2.14 B | $584.75 M(+14.2%) | $2.14 B(+3.5%) |
| Sept 2008 | - | $512.05 M(+16.1%) | $2.07 B(+14.4%) |
| June 2008 | - | $441.07 M(-27.2%) | $1.81 B(-3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $605.51 M(+18.3%) | $1.88 B(+6.5%) |
| Dec 2007 | $1.77 B(+44.9%) | $511.99 M(+103.8%) | $1.77 B(+1.9%) |
| Sept 2007 | - | $251.20 M(-50.9%) | $1.73 B(+0.0%) |
| June 2007 | - | $511.72 M(+4.3%) | $1.73 B(+16.5%) |
| Mar 2007 | - | $490.49 M(+2.3%) | $1.49 B(+22.1%) |
| Dec 2006 | $1.22 B(+72.6%) | $479.51 M(+91.2%) | $1.22 B(+13.9%) |
| Sept 2006 | - | $250.76 M(-5.7%) | $1.07 B(+57.9%) |
| June 2006 | - | $265.90 M(+19.8%) | $677.40 M(-3.3%) |
| Mar 2006 | - | $221.89 M(-33.0%) | $700.31 M(-0.8%) |
| Dec 2005 | $705.64 M(+38.9%) | $331.01 M(-334.1%) | $705.64 M(+42.5%) |
| Sept 2005 | - | -$141.40 M(-149.0%) | $495.26 M(-38.3%) |
| June 2005 | - | $288.81 M(+27.1%) | $803.30 M(+26.1%) |
| Mar 2005 | - | $227.22 M(+88.4%) | $636.98 M(+25.4%) |
| Dec 2004 | $507.96 M(+116.5%) | $120.63 M(-27.6%) | $507.96 M(+4.3%) |
| Sept 2004 | - | $166.64 M(+36.0%) | $487.24 M(+30.0%) |
| June 2004 | - | $122.49 M(+24.7%) | $374.92 M(+20.2%) |
| Mar 2004 | - | $98.21 M(-1.7%) | $311.87 M(+32.9%) |
| Dec 2003 | $234.61 M(+215.3%) | $99.91 M(+84.0%) | $234.61 M(+37.8%) |
| Sept 2003 | - | $54.31 M(-8.6%) | $170.24 M(-3.7%) |
| June 2003 | - | $59.44 M(+183.8%) | $176.70 M(+49.2%) |
| Mar 2003 | - | $20.94 M(-41.1%) | $118.47 M(+59.2%) |
| Dec 2002 | $74.41 M(-158.6%) | $35.55 M(-41.5%) | $74.41 M(+1502.3%) |
| Sept 2002 | - | $60.77 M(+4922.0%) | $4.64 M(-105.3%) |
| June 2002 | - | $1.21 M(-105.2%) | -$87.22 M(-27.2%) |
| Mar 2002 | - | -$23.11 M(-32.4%) | -$119.85 M(-5.6%) |
| Dec 2001 | -$126.98 M(+232.4%) | -$34.22 M(+10.0%) | -$126.98 M(+9.3%) |
| Sept 2001 | - | -$31.10 M(-1.0%) | -$116.17 M(+22.5%) |
| June 2001 | - | -$31.41 M(+3.9%) | -$94.83 M(+50.8%) |
| Mar 2001 | - | -$30.25 M(+29.2%) | -$62.89 M(+64.6%) |
| Dec 2000 | -$38.20 M(-39.0%) | -$23.41 M(+139.8%) | -$38.20 M(+61.9%) |
| Sept 2000 | - | -$9.76 M(-1955.7%) | -$23.59 M(-34.2%) |
| June 2000 | - | $526.00 K(-109.5%) | -$35.87 M(-36.2%) |
| Mar 2000 | - | -$5.56 M(-36.8%) | -$56.25 M(-10.2%) |
| Dec 1999 | -$62.60 M(+22.0%) | -$8.80 M(-60.1%) | -$62.60 M(-5.3%) |
| Sept 1999 | - | -$22.04 M(+11.0%) | -$66.10 M(-6.3%) |
| June 1999 | - | -$19.85 M(+66.6%) | -$70.56 M(+25.1%) |
| Mar 1999 | - | -$11.91 M(-3.1%) | -$56.41 M(+10.0%) |
| Dec 1998 | -$51.30 M(-5.9%) | -$12.30 M(-53.6%) | -$51.30 M(-40.2%) |
| Sept 1998 | - | -$26.50 M(+364.9%) | -$85.80 M(+24.9%) |
| June 1998 | - | -$5.70 M(-16.2%) | -$68.70 M(+7.7%) |
| Mar 1998 | - | -$6.80 M(-85.5%) | -$63.80 M(+17.1%) |
| Dec 1997 | -$54.50 M(+230.3%) | -$46.80 M(+397.9%) | -$54.50 M(+1334.2%) |
| Sept 1997 | - | -$9.40 M(+1075.0%) | -$3.80 M(-167.9%) |
| June 1997 | - | -$800.00 K(-132.0%) | $5.60 M(-186.2%) |
| Mar 1997 | - | $2.50 M(-35.9%) | -$6.50 M(-60.6%) |
| Dec 1996 | -$16.50 M(-28.3%) | $3.90 M(>+9900.0%) | -$16.50 M(-19.1%) |
| Sept 1996 | - | $0.00(-100.0%) | -$20.40 M(-21.8%) |
| June 1996 | - | -$12.90 M(+72.0%) | -$26.10 M(+22.5%) |
| Mar 1996 | - | -$7.50 M(+31.6%) | -$21.30 M(-27.1%) |
| Dec 1995 | -$23.00 M(-16.1%) | - | - |
| Sept 1995 | - | -$5.70 M(-29.6%) | -$29.20 M(+8.6%) |
| June 1995 | - | -$8.10 M(+8.0%) | -$26.90 M(-1.8%) |
| Mar 1995 | - | -$7.50 M(-5.1%) | -$27.40 M(+2.6%) |
| Mar 1995 | -$27.40 M(+22.3%) | - | - |
| Dec 1994 | - | -$7.90 M(+132.4%) | -$26.70 M(+6.4%) |
| Sept 1994 | - | -$3.40 M(-60.5%) | -$25.10 M(+0.8%) |
| June 1994 | - | -$8.60 M(+26.5%) | -$24.90 M(+11.2%) |
| Mar 1994 | -$22.40 M(+151.7%) | -$6.80 M(+7.9%) | -$22.40 M(+10.9%) |
| Dec 1993 | - | -$6.30 M(+96.9%) | -$20.20 M(+20.2%) |
| Sept 1993 | - | -$3.20 M(-47.5%) | -$16.80 M(+30.2%) |
| June 1993 | - | -$6.10 M(+32.6%) | -$12.90 M(+44.9%) |
| Mar 1993 | -$8.90 M(+140.5%) | -$4.60 M(+58.6%) | -$8.90 M(+107.0%) |
| Dec 1992 | - | -$2.90 M(-514.3%) | -$4.30 M(+207.1%) |
| Sept 1992 | - | $700.00 K(-133.3%) | -$1.40 M(-33.3%) |
| June 1992 | - | -$2.10 M | -$2.10 M |
| Mar 1992 | -$3.70 M(+54.2%) | - | - |
| Mar 1991 | -$2.40 M | - | - |
FAQ
- What is Gilead Sciences annual cash flow from operations?
- What is the all time high annual CFO for Gilead Sciences?
- What is Gilead Sciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Gilead Sciences?
- What is Gilead Sciences quarterly CFO year-on-year change?
- What is Gilead Sciences TTM cash flow from operations?
- What is the all time high TTM CFO for Gilead Sciences?
- What is Gilead Sciences TTM CFO year-on-year change?
What is Gilead Sciences annual cash flow from operations?
The current annual CFO of GILD is $8.01 B
What is the all time high annual CFO for Gilead Sciences?
Gilead Sciences all-time high annual cash flow from operations is $21.25 B
What is Gilead Sciences quarterly cash flow from operations?
The current quarterly CFO of GILD is $4.31 B
What is the all time high quarterly CFO for Gilead Sciences?
Gilead Sciences all-time high quarterly cash flow from operations is $5.79 B
What is Gilead Sciences quarterly CFO year-on-year change?
Over the past year, GILD quarterly cash flow from operations has changed by +$2.14 B (+98.66%)
What is Gilead Sciences TTM cash flow from operations?
The current TTM CFO of GILD is $10.02 B
What is the all time high TTM CFO for Gilead Sciences?
Gilead Sciences all-time high TTM cash flow from operations is $21.25 B
What is Gilead Sciences TTM CFO year-on-year change?
Over the past year, GILD TTM cash flow from operations has changed by +$2.02 B (+25.18%)